Fondaparinux
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Fondaparinux?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by Viatris. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Arixtra |
AHFS/Drugs.com | Monograph |
License data |
|
Routes of administration | Subcutaneous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | N/A |
Protein binding | 94% |
Metabolism | renally excreted unchanged |
Elimination half-life | 17-21 hours[1] |
Identifiers | |
CAS Number |
|
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C31H43N3Na10O49S8 |
Molar mass | 1728.03 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Close